Cooper Companies | COO - Текущие активы





Текущие активы Изменить Дата
Abbott USD 25.51B 488M 2026-03
Align Technology USD 2.66B 38.87M 2026-03
AtriCure USD 313.69M 8.82M 2026-03
Avanos Medical USD 325M 30.4M 2026-03
Bausch Health Companies USD 5.98B 179M 2026-03
Baxter International USD 6.85B 25M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Becton, Dickinson and Co. USD 8.01B 1.18B 2026-03
Boston Scientific USD 8.68B 110M 2026-03
Cooper Companies USD 2.3B 166M 2026-03
Dentsply International USD 1.85B 178M 2026-03
Dexcom USD 4.33B 298.4M 2026-03
Edwards Lifesciences USD 6.23B 510.2M 2026-03
Globus Medical USD 2.2B 72.51M 2026-03
Haemonetics USD 834.88M 108.8M 2026-03
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.71B 204.5M 2026-03
Integra LifeSciences USD 1.17B 12.47M 2026-03
Intuitive Surgical USD 11.52B 881.5M 2026-03
J&J USD 59.17B 3.55B 2026-03
Medtronic USD 24.07B 75M 2025-12
Merit Medical Systems USD 1.1B 61.62M 2026-03
Novartis USD 30.46B 2.26B 2025-12
ResMed USD 4.06B 245.26M 2026-03
STAAR Surgical USD 312.4M 853K 2026-03
Steris USD 2.39B 108.4M 2026-03
Stryker USD 13.34B 1.42B 2026-03
Tandem Diabetes Care USD 887.1M 268.96M 2026-03
Teleflex USD 1.86B 78.67M 2026-03
Utah Medical Products USD 97.74M 1.21M 2025-12
Zimmer Biomet Holdings USD 4.96B 157.4M 2026-03